brinzolamide

FDA Drug Profile — BRINZOLAMIDE, Azopt

brinzolamide is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including BRINZOLAMIDE, Azopt. Available dosage forms: powder, suspension/ drops.

Drug Details

Generic Name
brinzolamide
Brand Names
BRINZOLAMIDE, Azopt
Application Number
ANDA211914
Sponsor
Isomedix Operations Inc
NDC Codes
6
Dosage Forms
POWDER, SUSPENSION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
BRINZOLAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. ( 1 )